Publications by authors named "S Handanagic"
Article Synopsis
- * From 2017 to 2022, the study evaluated HCV incidence among repeat blood donors, finding a decline in seroconversion rates from 408 to 218 per 100,000 person-years, and infection rates from 172 to 118 per 100,000 person-years.
- * The highest incidences of HCV were among males, younger adults (18-39), and those last tested in prisons, indicating a need for targeted prevention and treatment efforts in these high-risk groups in Georgia.
A nationwide serosurvey among adults in 2021 showed a 2.7% (95% confidence interval [CI]: 2.3%-3.
View Article and Find Full Text PDFArticle Synopsis
- * Researchers assessed infection control practices and testing methods across 27 dialysis centers in Georgia during a facility-based survey conducted from April to June 2021.
- * Findings revealed significant gaps in infection control, with a notable number of patients seroconverting for both HCV and HBV, indicating a need for stricter adherence to safety protocols to minimize transmission risks.
About 80% of persons with chronic hepatitis B virus (HBV) infection in the United States are non-US-born. Despite improvements in infant hepatitis B vaccination globally since 2000, work remains to attain the World Health Organization's (WHO) global 2030 goal of 90% vaccination. We explore the impacts on the United States of global progress in hepatitis B vaccination since 2000 and of achieving WHO hepatitis B vaccination goals.
View Article and Find Full Text PDFBackground: Characterizing acute and chronic hepatitis C virus (HCV) infection and HIV/HCV co-infection among persons who inject drugs (PWID) can inform elimination efforts.
Methods: During 2018 National HIV Behavioral Surveillance in 10 U.S.